The Long View

Ah, Regeneron (REGN). Once the golden child of ophthalmology, now the grizzled veteran of biotech, hobbling through a few Eylea-induced aches and pains. But here’s the punchline: this old dog is learning some new tricks. And Wall Street is finally starting to notice. After a year in the earnings penalty box, Regeneron just delivered a […]

Ten Reasons Why I Only Execute Vertical Call Debit Spreads

At today’s Mad Hedge Biweekly Strategy Webinar, I received an excellent question: Why is the Vertical Call Debit Spread my favorite trading vehicle when markets are going rising? So let me ask you this: How would you like to play blackjack knowing that the dealer would bust 90% of the time? What if you played […]

November 3, 2025

  (HEALTHCARE IS AN UNDERVALUED SECTOR – IT MIGHT BE TIME TO TAKE A LOOK)   November 3, 2025   Hello everyone   WEEK AHEAD CALENDAR Monday, Nov. 3 9:45 a.m. S&P final U.S. manufacturing Oct. PMI 10:00 ISM manufacturing (OCT.) 10:00 Construction spending (Sept.) Earnings:  Eastman Chemical, Clorox, Palantir Technologies, Vertex Pharmaceuticals, Diamondback Energy, […]